Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Xeris Pharmaceuticals Inc (NQ: XERS )

4.400 USD -0.540 (-10.93%)
Streaming Delayed Price Updated: 11:40 AM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Xeris Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference
Paul R. Edick, Chairman and CEO of Xeris, will participate in a fireside chat at the 9th Annual SVB Leerink Global Healthcare Conference on Feb 25. 
From Business Wire News Releases
35 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers Stealth BioTherapeutics, Inc.(NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market ... 
Tags ARDX Biotechnology Markets
From Benzinga
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags WST XENE ESALY
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 95 companies set new 52-week lows. Interesting Facts: St. Augustine Gold(OTC: ... 
Tags SKT Markets Intraday Update
From Benzinga
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CYTK PDSB IRWD
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 136 stocks hit new 52-week lows. Noteworthy Points: The largest company in terms of market cap to set a new ... 
Tags FLWPF UVSE PTE
From Benzinga
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga Pre/Market Outlook News
From Benzinga
13 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares moved upwards by 31.6% to $0.30 during Wednesday's pre-market ... 
Tags XERS Market News REXN
From Benzinga
12 Biotechnology Stocks Moving In Wednesday's Pre-Market Session
Gainers • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock moved upwards by 31.6% to $0.30 during Wednesday's pre-market ... 
Tags PTE ADMA Pre/Market Outlook
From Benzinga
94 Biggest Movers From Yesterday
Gainers Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license ... 
Tags KOD Building Products IIVI
From Benzinga
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
From GlobeNewswire News Releases
71 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sprint Corporation (NYSE: S) shares jumped 73.1% to $8.31 following a report suggesting a US judge is expected to rule in ... 
Tags Movers ASNA BCLI
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET on Tuesday, 92 companies set new 52-week lows. Interesting Facts: Royal Dutch Shell(OTC: ... 
Tags INND SEXHF FEWP
From Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TGTX MBRX GLYC
From Benzinga
36 Stocks Moving in Tuesday's Pre-Market Session
Gainers Sprint Corporation (NYSE: S) rose 64.2% to $7.88 in pre-market trading following a report suggesting a US judge is ... 
Tags News Pre/Market Outlook Benzinga
From Benzinga
Xeris Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of Common Stock
From GlobeNewswire News Releases
NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report
From InvestorBrandNetwork
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635
Tags News Benzinga XERS
From Benzinga
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags ACST ALPMY RGEN
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares climbed 182.6% to $21.87 following news the company completed a recapitalization and ... 
Tags RADA Human Resource & Employment Services BTAI
From Benzinga
27 Stocks Moving in Wednesday's Pre-Market Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 248.2% to $26.95 in pre-market trading after the company reported completion ... 
Tags MTL BYND BNTX
From Benzinga
48 Biggest Movers From Yesterday
Gainers Genetic Technologies Limited (NASDAQ: GENE) gained 120% to close at $4.51. Cellect Biotechnology Ltd. (NASDAQ: APOP) ... 
Tags LEJU CEI Markets
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares climbed 103.8% to $4.8901 after the company announced it has received ... 
Tags MTNB NDRA Trading Ideas
From Benzinga
Xeries Aces Study Of RTU Glucagon For Exercise-Induced Hypoglycemia In Diabetics
Xeris Pharmaceuticals Inc (NASDAQ: XERS) shares are advancing on above-average volume Tuesday following a positive data readout from the ... 
Tags Biotech XERS Movers
From Benzinga
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags EVLO Benzinga News
From Benzinga
20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers Cellect Biotechnology, Inc.(NASDAQ: APOP) shares moved upwards by 212.5% to $7.50 during Tuesday's pre-market ... 
Tags General Trading Ideas LPCN
From Benzinga
16 Stocks Moving in Tuesday's Pre-Market Session
Gainers Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) shares rose 21.6% to $7.04 in pre-market trading after the company announced ... 
Tags BNTX Premarket Movers Electrical Components & Equipment
From Benzinga
Xeris Pharmaceuticals Announces Positive Results from the In-Clinic Stage of a Phase 2 Study of Its Developmental Ready-To-Use (RTU) Glucagon in Patients at Risk of Hypoglycemia During and after Aerob
Xeris today announced positive results from the in-clinic stage of a Phase 2 study of its developmental RTU glucagon for EIH. 
From Business Wire News Releases
53 Biggest Movers From Friday
Gainers Cassava Sciences, Inc. (NASDAQ: SAVA) shares jumped 34% to close at $9.65 on Friday. NanoViricides, Inc. (NYSE: NNVC) ... 
Tags VIVE Specialty Chemicals FIXX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.